Highlights
NASDAQ: ARQL       Arqule Inc
Last Price Today's Change   Day's Range   Trading Volume
7.88   +0.055 (0.70%)  7.65 - 7.95  3,152,100

Overview

 
Avg Volume (4 weeks):2,184,930
4 Weeks Range:6.98 - 10.35
4 Weeks Price Volatility (%):
26.71%
52 Weeks Range:2.23 - 12.22
52 Weeks Price Volatility (%):
56.56%
Average Price Target: 11.00
Price Target Upside/Downside: +3.12

Headlines



No recent Headlines for this stock.


Business Background

Arqule Inc is a biopharmaceutical company, engaged in the research and development of therapeutics to treat cancers and rare diseases. The objective of the company is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of the patients. These drugs focus on the biological pathways implicated in a range of cancers and certain non-oncology indications. Product portfolios of the group include Tivantinib, ARQ 087, ARQ 092, ARQ 761, and ARQ 751. Geographically, the firm operates through the region of United States.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers